Clinical Trial Update: Psoriatic Arthritis Study of Izokibep [Phase 2, Phase 3]

View source ↗

Summary

ACELYRIN's Phase 2/3 trial of izokibep for psoriatic arthritis was terminated, and the results have been posted. Details on efficacy and safety are included in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Izokibep (izokibep)

Snippet

Sponsor: ACELYRIN Inc. | Conditions: Psoriatic Arthritis | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-05-23